Rating date
May 29, 2026
73 days ago
Gilead Sciences (GILD) Stock Analysis
HOLDGILD Equity Research — HOLD — May 2026
Desk view
HOLD
5D move
—
Neutral (HOLD unscored)
Peer rank
69p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · GILD
The clearest and most impactful catalyst in the review period. Gilead received accelerated FDA approval for Hepcludex (bulevirtide-gmod) as the first-ever treatment for hepatitis delta virus (HDV). Multiple outlets (Stocktwits, Insider M...
Desk rating
HOLD
Tactical HOLD · 12M HOLD
Horizon
Short to medium term
Confidence
Medium
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
HOLD
Catalysts
- The technical setup has improved markedly since late April, with momentum shifting from bearish to bullish.
- RSI in the low 50s leaves room for further upside before overbought levels are reached.
- The MACD histogram is rising and now positive, supporting a bullish bias, but the MACD line needs to cross above its signal line and zero for full confirmation.
Risks
- Event-driven repricing risk if expectations diverge from incoming evidence.
Market chart
Price context alongside the research narrative.
GILD Research Note
Full desk note for May 29, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
GILD Equity Research Note
GILD Stock Rating Summary
GILD bias
HOLD
Horizon
Short to medium term
GILD key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
GILD catalyst watch
The technical setup has improved markedly since late April, with momentum shifting from bearish to bullish.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
Medium
How the call aged · 5D
—Neutral (HOLD unscored)Peer 69pExpandCollapse
How the call aged · 5D
—Neutral (HOLD unscored)Peer 69p
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-05-30T11:24:18.165764+00:00.
5D move
—
2026-05-29 → awaiting
Outcome
Neutral (HOLD unscored)
5D trend
+3.01%
Vol (20D ann.)
+21.57%
vs SPY: +1.16%
Close 134.43 → — (USD, vendor closes)
Batch scorecard · 2026-05-29 · GILD